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A B S T R A C T
Signaling of plasma membrane receptors can be regulated by endocytosis at different levels, including
receptor internalization, endocytic sorting towards degradation or recycling, and using endosomes as
mobile signaling platforms. Increasing number of reports underscore the importance of endocytic
mechanisms for signaling of cytokine receptors. In this short review we present both consistent and
conﬂicting data regarding endocytosis and its role in signaling of receptors from the tumor necrosis factor
receptor superfamily (TNFRSF) and those for interleukins (ILRs) and interferons (IFNRs). These receptors
can be internalized through various endocytic routes and most of them are able to activate downstream
pathways from endosomal compartments. Moreover, some of the cytokine receptors clearly require
endocytosis for proper signal transduction. Still, the data describing internalization mechanisms and fate
of cytokine receptors are often fragmentary and barely address the relation between their endocytosis
and signaling. In the light of growing knowledge regarding different mechanisms of endocytosis,
extending it to the regulation of cytokine receptor signaling may improve our understanding of the
complex and pleiotropic functions of these molecules.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Endocytosis is coupled to regulation of signaling initiated by
plasma membrane receptors. Initially, internalization of the
activated receptors was considered only as a means for signal
attenuation, but now it is clear that endocytosis also regulates the
duration of receptor signaling as well as speciﬁcity of signaling
outputs (reviewed in Barbieri et al. [1]). Endosomes can serve as
mobile signaling platforms facilitating formation of multiprotein
signaling assemblies and therefore enabling efﬁcient signal
transduction in space and time. Signaling events that are initiated
at the plasma membrane may continue at the endosomal
compartments and terminate by incorporation of the receptorAbbreviations: CIE, clathrin-independent endocytosis; CME, clathrin-mediated endo
receptor; GPI-AP, glycosylphosphatidylinositol-anchored proteins; IFN, interferon; IFNA
receptor; IL, interleukin; ILR, interleukin receptor; ILV, intraluminal vesicle; JNK, c-Jun N
methyl-b-cyclodextrin; PI3K, phosphoinositide 3-kinase; RTK, receptor tyrosine kinase
* Corresponding author at: International Institute of Molecular and Cell Biology, Ksie
E-mail address: miaczynska@iimcb.gov.pl (M. Miaczynska).
1 These authors contributed equally to this work.
http://dx.doi.org/10.1016/j.cytogfr.2016.07.002
1359-6101/ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article uninto the intraluminal vesicles (ILVs) of the multivesicular bodies
(MVBs).
Although a great number of biochemical and imaging
approaches have been undertaken to study how different
endocytic routes affect receptor signaling, they have been applied
to only a few model receptors with a major focus on epidermal
growth factor receptor (EGFR) [2]. Consequently, the review
articles published so far have described the involvement of
endocytosis in regulation of receptor tyrosine kinases (RTKs),
such as EGFR, or G protein-coupled receptors (GPCRs), such as
neurotransmitter or chemokine receptors [3–5]. Conversely, no
reviews comprehensively summarize the role of endocytosis in
signaling of cytokine receptors.cytosis; DRM, detergent-resistant microdomains; EGFR, epidermal growth factor
R, type I interferon receptor; IFNGR, type II interferon receptor; IFNR, interferon
-terminal kinase; LTbR, lymphotoxin b receptor; MVB, multivesicular body; MbCD,
; TNF, tumor necrosis factor; TNFRSF, tumor necrosis factor receptor superfamily.
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der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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superfamily (TNFRSF), interleukin receptors (ILRs) and interferon
receptors (IFNRs). As opposed to RTKs (tyrosine kinases) and TGFb
receptor superfamily (serine/threonine kinases) they do not
possess any intrinsic kinase activity and unlike GPCRs they do
not transmit signals through G proteins. Instead, they depend on
multiple signaling adaptors that mediate inﬂammatory and stress
responses via signaling pathways involving NF-kB and MAPK (TNF
receptor and IL-1 receptor superfamilies) or STAT and MAPK
(receptors for IFNs and most of the ILs).
1.1. Mechanisms of receptor internalization
Receptor-mediated endocytosis is initiated at the plasma
membrane by several distinct internalization mechanisms
(Fig. 1). Their traditional division is based on the involvement of
clathrin protein (clathrin-mediated endocytosis, CME) or its
absence (clathrin-independent endocytosis, CIE). In CME, activated
receptor induces recruitment of clathrin adaptors, such as the AP2
complex, while the subsequent formation of the clathrin coat
stabilizes the membrane curvature and drives the invagination. In
the ﬁnal step, the vesicle is released from the plasma membrane by
the large GTPase dynamin that assembles around the bud neck
[6–8].
The mechanisms of clathrin-independent internalization routes
are less well deﬁned. In fact, CIE is a common designation for
several distinct internalization pathways, which depend on actin
polymerization and its regulators, such as actin polymerizing
factors and Rho GTPases [9]. Clathrin-independent internalization
often takes place at the plasma membrane microdomains calledFig. 1. Receptor-mediated internalization and endocytic trafﬁcking routes. Plasma memb
independent (CIE) endocytosis. CIE often occurs at the plasma membrane microdomains 
of internalized vesicles and on involvement of the listed molecular regulators. After intern
recycling endosomes or multivesicular bodies (MVB). Recycling endosomes return the rec
into intraluminal vesicles (ILV). Subsequent maturation of MVBs to late endosomes and 
acidiﬁcation of endosomal lumen is marked by progressive color change from blue to lipid rafts, that initially were viewed as the sole common feature of
many CIE routes. Lipid rafts are enriched in cholesterol and
glycosphingolipids, that create a liquid-ordered microenvironment
in a less ordered surrounding. Lipid rafts are important domains for
assembly of complexes transducing extracellular signals. Several
examples are presented in this review, whereas other well
established signaling events initiated in lipid rafts are T-cell
receptor-dependent signaling cascades [10] or H-Ras-mediated Raf
activation [11]. Due to their small size, native lipid rafts cannot be
observed in standard light microscopy, that was a reason for using
rather crude techniques to study their function. One of them is
cholesterol depletion, which can potentially affect non-raft
elements of the plasma membrane. Another approach enables
separation of cell membranes to detergent-soluble or detergent-
resistant fractions, the latter containing lipid raft microdomains.
However, beside other limitations, this technique cannot distin-
guish the plasma membrane from intracellular membranes.
Therefore, the data acquired with both methods have to be
interpreted with caution and need validation with more precise
approaches [11].
Detailed molecular mechanisms and functional classiﬁcation of
the CIE pathways are under intense research and their nomencla-
ture is a matter of debate. Still, they can be subdivided depending
on the involvement of dynamin. The best studied dynamin-
dependent CIE is caveolar internalization [12]. Caveolins are
integral membrane proteins resident in the lipid rafts. In the
nonmuscle cells, caveolins 1 and 2 bind additional adaptors and
coat small membrane domains, forming a cup-shaped invagination
called caveolae. Another well-deﬁned CIE route is IL-2 receptor
(IL-2R) endocytosis, described in detail later in this review. Brieﬂy,rane receptors can be internalized by means of clathrin-mediated (CME) or clathrin-
called lipid rafts and can be subdivided based on involvement of dynamin in scission
alization, receptors are trafﬁcked to early endosomes from where they are sorted to
eptors to the plasma membrane, while MVBs sequester them through incorporation
their fusion with lysosomes leads to degradation of ILVs and their cargo. Increasing
grey (see main text for details).
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Rac1 and RhoA for internalization [13]. Recently, IL-2R was
described as a cargo of fast endophilin-mediated endocytosis
(FEME), where endophilins cooperate with dynamin and actin
cytoskeleton in scission of vesicles formed in a clathrin-indepen-
dent manner [14,15].
Other CIE pathways do not require dynamin activity but instead
involve different mechanisms of vesicle scission from the plasma
membrane which remain unresolved. They are mainly character-
ized by the internalized cargo and several crucial components.
Flotilins can induce membrane invaginations and mediate
endocytosis of ﬂuid-phase components and GPI-anchored proteins
(GPI-AP). Another route is described by internalization of GPI-APs,
ﬁrst trafﬁcking to plasma membrane-derived clathrin-indepen-
dent carriers (CLICs) and then to the specialized GPI-AP enriched
early endosomal compartment (GEEC) [16,17]. This CLIC/GEEC
route is driven extracellularly by galectin 3, that clusters receptors
and induces the membrane curvature [18], and intracellularly by
activation of Rho GTPase Cdc42 that induces actin polymerization
[19]. Various cargo can internalize through this entry portal,
including GPI-APs, transmembrane proteins and considerable
amounts of extracellular ﬂuids. Similar cargoes can enter the cell
by endocytosis regulated by ADP ribosylation factor 6 (Arf6), a
plasma membrane localized small GTPase [9]. Moreover, large
volumes of extracellular ﬂuid but also some receptors, can be
internalized by macropinocytosis [20].
1.2. Endocytic sorting
Internalized cargo, independently of the entry mechanism, can
be either recycled back to the plasma membrane or sorted towards
degradation. The two routes diverge at the stage of early
endosomes, also called sorting endosomes, marked by small
GTPase Rab5 and its effectors EEA1 or APPL1 [21–23]. Subsequent
sorting events are mediated by different subsets of endosomal
compartments.
The recycling of receptors is necessary to renew their pool at the
plasma membrane for another cycle of ligand import. It can
proceed from the early endosomes directly to the plasma
membrane, regulated by Rab4 [24], or through Rab11-positive
recycling endosomes [25,26]. In fact, in the absence of a
degradative mark (such as ubiquitin), recycling is the default
route for receptors.
Alternatively, if the receptor undergoes ubiquitylation on the
plasma membrane, it will be sorted from early endosomes towards
degradation. Ubiquitylated cargo is recognized at the limiting
membrane of the early endosomes by hepatocyte growth factor
regulated tyrosine kinase substrate (Hrs), the component of the
Endosomal Sorting Complex Required for Transport-0 (ESCRT-0)
[27,28]. The four ESCRT complexes from 0 to III sequentially
assemble on early endosomes, clustering receptors and driving
formation of the intraluminal vesicles (ILVs), to which the
receptors are targeted [29] (Fig.1). Formation of ILVs is prerequisite
for maturation of multivesicular endosomes (MVEs), named also
multivesicular bodies (MVBs), which are considered transition
structures between early and late endosomes [30]. Other hall-
marks of such maturation are the increasing acidiﬁcation to pH
5.5 and exchange of Rab proteins from Rab5 to Rab7, called the
Rab conversion [31].
The Rab7-positive late endosomes fuse with the lysosomes.
Enzymes present in the lysosomes degrade their contents [32],
including the receptor-enriched ILVs. The lysosomes are the last
compartments in the degradative route and the most acidiﬁed,
reaching pH 4.6 [33], but like other endosomes they are dynamic
organelles undergoing reformation after fusion events [34].1.3. Mechanisms of endocytic regulation of receptor signaling outputs
If we follow routes of receptor endocytosis, it turns out that
every step of the trafﬁcking can affect the signaling output. Firstly,
internalization can attenuate signaling by restricting amounts of
the receptor available for an extracellular ligand. For example,
upon WNT binding the Frizzled receptor is internalized and
degraded, that is necessary for proper embryonic development
[35].
Secondly, for some receptors membrane surfaces of endosomes
serve as platforms for assembly of signaling complexes and
therefore more discretely modulate signal transduction. This is the
case for G-protein-coupled receptors (GPCRs) that remain associ-
ated with b-arrestins, both at the plasma membrane and endo-
somes, enabling signal transduction from the two locations
[36–39]. In addition, endosomes may serve as platforms for
unique signals, not initiated elsewhere. As endosomes are rich in
phosphatidylinositol 3-phosphate, they can recruit proteins that
have a FYVE domain, which binds this lipid [40]. It was shown that
TGFb signaling utilizes adaptors containing a FYVE domain, such as
SARA (Smad anchor for receptor activation) [41] and endoﬁn [42]
to activate transcription factors Smad 2/3 and Smad4, respectively.
Endosomes in dendritic cells were also shown to serve as
specialized platforms for sensing of pathogens by the cytosolic
NOD2 receptor [43].
Thirdly, the fate of receptors is regulated by the endocytic
sorting with two possible and contrasting outcomes. The signal
will be either attenuated, when receptor is sorted to ILVs and can
no longer associate with the cytoplasmic adaptors, or enhanced, if
the receptor is recycled to the plasma membrane to restore the
pool available for the ligand. This mechanism can be also coupled
to speciﬁc internalization routes. The best studied example is the
trafﬁcking of EGFR. This receptor was shown to undergo CME when
exposed to low doses of the ligand and to follow a CIE if high ligand
concentrations were applied. It was proposed that EGFR internal-
ized via CME is recycled to the cell surface that prolongs the
signaling. In contrast, clathrin-independent internalization
preferentially committed the receptor to degradation [44].
The effects of internalization and trafﬁcking of cytokine
receptors presented in this review mostly lack this level of
understanding, but many hints suggest that endocytosis and
sorting play a major role in regulating cell response to cytokines.
2. TNFR superfamily receptors
The tumor necrosis factor receptor superfamily (TNFRSF)
consists of 29 receptors, all being type I transmembrane proteins.
They are activated by ligand-induced multimerization and operate
through interactions of a receptor cytoplasmic tail with signaling
adaptors. Nine of them, such as TNFRI, Fas (CD95) and TRAIL
receptors, possess a cytoplasmic interaction module called the
death domain (DD) which mediates proapoptotic signaling. TNFR1
is a pleiotropic receptor as it can induce both canonical NF-kB as
well as proapoptotic pathways [45]. The canonical NF-kB signaling
is mediated by association of the receptor with RIP1 kinase and
TRADD and TRAF2 adaptors (complex I), followed by subsequent
IkBa degradation and activation of NF-kB dimer RelA:p50. The key
events of the proapoptotic cascade initiation include association of
TRADD and RIP1 with FADD and caspase-8 forming cytoplasmic
complex II [46]. The role of endocytosis in the function of death
receptors has been reviewed [47,48].
Other receptors from this superfamily are non-death receptors,
such as LTbR and CD40, that induce pro-survival MAPK and NF-kB
pathways. The latter involves canonical NF-kB signaling, but also
the noncanonical NF-kB branch driven by accumulation of NIK
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formation of RelB:p52 transcription factor.
2.1. TNFR1
TNFR1 is activated by TNFa, which is the founding member of
the TNF ligand superfamily. Upon activation, the death domain of
TNFRI associates with adaptors and leads to activation of the pro-
survival canonical NF-kB and the c-Jun N-terminal kinase (JNK)
cascades or the secondary apoptotic cascade through the complex
II [46].
Early studies of TNFRI internalization showed that upon TNFa
stimulation, TNFR1 was internalized [49] and did not undergo
recycling [50]. Although early data of electron microscopy
suggested that TNFRI could enter the cell via clathrin-coated pits
[51], subsequent studies showed that it is internalized through
caveolae or lipid rafts [52–54]. Upon TNFa stimulation, TNFR1 co-
localized with caveolin in cholesterol-rich lipid domains, but not
with clathrin-coated pits [53].
The cholesterol- and sphingolipid-enriched membrane micro-
domains were shown as sites of TNFR1 ubiquitylation and
recruitment of signaling molecules from complex I, while
inhibition of endocytosis by several chemical agents partly
perturbed both TNF uptake as well as TNF-induced gene activation
[52,55]. These pieces of evidence argue for requirement of
endocytosis in TNF signaling. In addition, lipid raft disruption
was shown to block IkBa phosphorylation and to sensitize cells to
TNFa-induced apoptosis [52], suggesting that TNFRI requires
redistribution to lipid rafts to induce the NF-kB response, but not
apoptosis. The study of Schneider-Brachert et al. supported this
view, as they proposed that the initial TNFR1 signaling through the
complex I (NF-kB and c-Jun pathways) is independent of receptor
internalization and therefore originates from the plasma mem-
brane, whereas assembly of complex II was linked to receptor
internalization suggesting endosomal origin of the pro-apoptotic
signaling events [56].
Consistently with this model, D'Alessio et al. showed that
cholesterol depletion with methyl-b-cyclodextrin (MbCD) re-
duced receptor internalization but did not inhibit TNF-induced NF-
kB pathway [53]. Their next study showed that silencing of
caveolin-1 or ﬂotilin-2 did not affect the NF-kB activation [54].
Strikingly, caveolin silencing not only did not block internalization
of the receptor, but resulted in its redistribution to the early
endosomes [54]. Possibly, TNFRI relocates to lipid rafts after
stimulation but it can signal to NF-kB both from the plasma
membrane microdomains and outside of them. Meanwhile, as
TNFR1 internalization only partially depends on lipid rafts, the
endosomal proapoptotic signaling can take place even when the
plasma membrane cholesterol-rich microdomains are perturbed.
The notion that TNFa-induced MAPK signaling originated from the
plasma membrane was also conﬁrmed by evidence that inhibiting
dynamin function potentiated JNK and p38 phosphorylation
induced by TNFa and enhanced TNFa-induced physiological
responses [57].
The model of TNFR1-related compartmentalization of pro-
survival and death-inducing signaling cascades proposed by
Schneider-Brachert et al. has been expanded by their next studies
suggesting that the internalized receptor is sorted to the interior of
MVBs, where the pro-apoptotic signal is ampliﬁed through action
of acid sphingomyelinase (ASMase) [56,58–60]. However, this is in
conﬂict with the current knowledge of the receptor topology inside
the multivesicular bodies, as discussed elsewhere [61]. A
complementary mechanism of apoptotic signal transduction from
the surface of MVBs was proposed to involve protein Alix (ALG-2
interacting protein X; PDCD6IP). Alix associates with the mem-
branes and the ESCRT machinery when activated by calcium-binding ALG-2 (PDCD6) [62,63], and regulates MVB biogenesis and
EGFR sorting [64,65]. The work of Mahul-Mellier and colleagues
[66] provided evidence, that Alix and ALG-2 can form a complex
with pro-caspase 8 and TNFR1 on endosomes, thereby mediating
TNF-induced apoptosis downstream of the receptor internaliza-
tion. Alix binding to TNFRI depended on association with ESCRTs,
underscoring the role of MVBs in signal propagation. The same
study also conﬁrmed that TNFRI internalization and TNFRI-
induced cell death depended on activity of dynamin 2, supporting
the model for apoptotic signaling originating from endosomes.
The relation of TNFRI signaling and endocytosis is one of the
best studied among cytokine receptors. It is well established, that
TNF-induced apoptotic signaling requires endocytosis and endo-
somal machinery. Still, the receptor most probably uses many
internalization mechanisms but it is unclear what their exact
identity is and how they affect the signaling output.
2.2. Death receptors (DRs)
The spatial separation of apoptosis and non-death signaling
pathways seems to function also for the death receptor CD95 (Fas).
This is the prototypical death-inducting receptor, mainly studied in
the context of Fas ligand (FasL)-induced apoptosis. CD95 is rapidly
clustered and internalized (within 3–15 min) upon stimulation
with a soluble or transmembrane ligand, simultaneously inducing
apoptotic signaling [67,68]. Although association of the receptor
with the death-inducing signaling complex (DISC) elements such
as FADD and caspase 8 seemed to precede its internalization, the
DISC formation peaked at 30 min and depended on receptor
internalization. Interestingly, CD95 was shown to co-exist with
Rab4 and EEA1 in isolated receptosomes, suggesting that CD95
undergoes recycling towards the plasma membrane [68]. This
could potentially prolong CD95 signaling but also increase its
dependence on internalization. Importantly, blocking CD95 cell
entry inhibited apoptosis but enabled activation of NF-kB and
ERK1/2 [68]. The mechanisms of CD95 endocytosis seem to involve
its palmitoylation and enrichment in lipid rafts, which are needed
for induction of apoptosis [69–71]. Although this may point to
clathrin-independent internalization routes, several reports sug-
gest that CD95 endocytosis depends on actin cytoskeleton and its
regulator ezrin, but also partially on clathrin and dynamin [70,72–
75]. Involvement of these three elements may indicate that CD95
uses several cell entry routes, but their functional interconnections
remain unclear.
TRAIL receptor is also a well-studied inducer of apoptosis,
however its endocytosis is poorly deﬁned and most probably
various internalization mechanisms play a role in this process.
Receptors for the TRAIL ligand are also known as death receptors
(DR3, 4, 5, 6), where TRAILR1 (DR4) and TRAILR2 (DR5) are
signaling receptors, while DR3 and DR6 are decoy receptors. The
induced TRAILR2 was localized in electron-dense plasma mem-
brane invaginations resembling clathrin-coated pits [76] and
internalization of the TRAIL ligand depended on dynamin and
clathrin adaptor AP180C, but a fraction of the receptor was also
internalized via dynamin-independent mechanisms [77]. The later
fate of the receptor is assumed to involve its degradation. It was
suggested that TRAILR2 is directed to lysosomes where it continues
to signal and promotes release of lysosomal proteases to induce
apoptosis [78].
The requirement of endocytosis in TRAILR2 receptor signaling is
under debate, as it was shown to be both required [78] and
dispensable [77] for apoptotic signaling. According to Akazawa
et al. [78], dominant-negative mutant of dynamin 2 and silencing
of Rab7 inhibit apoptotic signaling induced by TRAILR2, which
suggests that both early and late trafﬁcking events are needed for
signal propagation. Interestingly, prolonged TRAIL treatment
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caspase-dependent cleavage of clathrin and its adaptor AP2 [76],
but the initial internalization rate of TRAIL occurs within minutes
and should not be affected by these proteolytic events.
Cumulatively, internalization of CD95 and TRAIL death recep-
tors is most likely required for their proapoptotic signaling.
2.3. Non-death TNFR superfamily receptors
The interplay of endocytosis and signaling of non-death TNFR
superfamily receptors is relatively poorly studied, with LTbR and
CD40 being few known examples. Both receptors exert their
function through activation of the canonical and noncanonical
NF-kB pathways. In vivo these receptors are activated by
membrane-bound ligands exposed on the surfaces of lymphocytes
[79,80].
LTbR does not possess a death domain, but contains TRAF-
binding sites that can interact with TRAF2, 3, 4 and 5 [81–83]. The
recruitment of TRAF2/5 to the LTbR tail induces the canonical
pathway, whereas binding of TRAF2 and TRAF3 activates the
noncanonical NF-kB branch. Importantly, spatial segregation of
TRAF protein pools associated with the receptor in each pathway
was proposed to facilitate separation of the two signaling cascades
[84]. Activation of the noncanonical NF-kB pathway was shown to
rely on dynamin-dependent internalization of LTbR, whereas the
canonical branch was not affected by blocking clathrin or dynamin
activities. Thus, similarly to TNFR1, the canonical NF-kB pathway
may be induced by LTbR at the plasma membrane, while
secondary signaling, in this case the noncanonical NF-kB, requires
endocytosis. The work of Ganeff et al. [84] offers an attractive
model for the separation of the two NF-kB signaling cascades by
spatial distribution of the receptor along with its adaptors, but
details of this regulation remain elusive and need further studies.
Endosomal signaling of LTbR is also possible in a ligand-
independent manner. Our recent work showed that depletion of
ESCRT components Tsg101, Vps28, UBAP1 (ESCRT-I) or CHMP4B
(ESCRT-III) leads to ligand-independent induction of the canonical
and noncanonical NF-kB pathway [85]. This activation strongly
depended on LTbR and TNFRI, which accumulated on enlarged
early endosomes and were activated independently of TNFa,
lymphotoxin or serum-derived ligands. Our results suggest that
cytokine receptors undergo constitutive internalization and on
endosomes can be sorted by ESCRTs towards lysosomal degrada-
tion. By this means the endocytic system could serve as a potent
guardian preventing spurious, ligand-independent signaling. It
remains an open question whether ligand-independent LTbR
signaling from endosomes activates both NF-kB branches or just
the noncanonical one.
Similarly to LTbR, CD40 can activate the canonical and
noncanonical NF-kB pathways but also signaling dependent on
p38, Akt, JNK and STAT5 [79,86,87]. The CD40 receptor is expressed
on antigen presenting cells (APCs), both professional such as B
cells, macrophages, dendritic cells as well as non-professional like
endothelial cells, vascular smooth muscle cells and ﬁbroblasts. The
CD40 molecule can be activated by a transmembrane ligand
present on T lymphocytes or its soluble counterpart shed from
platelets [79].
It is well established that CD40 becomes enriched within lipid
rafts and forms clusters in different cell types after induction with
the transmembrane ligand CD40L (CD154) or agonistic antibodies
[88–90]. Lipid rafts were also shown to be essential for CD40 ligand
clustering [91], recruitment of adaptors TRAF2 and TRAF3 [90,92]
and for phosphorylation of Akt, but not p38 or JNK, upon CD40
stimulation [93]. Interestingly, ceramide produced by acid
sphingomyelinase (ASMase) was necessary to drive CD40 ligand
clustering on the plasma membrane and to induce subsequent IL-12 production after treatment of lymphocytes with agonistic
antibodies [89]. Although involvement of lipid rafts in CD40
clustering is well documented, the mechanisms of receptor
internalization or its trafﬁcking routes remain obscure. Two
studies attempted to address these questions, but the data
obtained with overexpressed receptor were difﬁcult to interpret
[94,95].
3. IL-1 superfamily receptors
The IL-1 receptor (IL-1R) superfamily contains several trans-
membrane protein complexes including 4 signaling receptors, IL-1,
IL-18, IL-33 and IL-36 receptors [96]. The best studied among this
group, IL-1R, is present predominantly on the surface of B- and T-
lymphocytes and macrophages but also of ﬁbroblasts and many
other cell types. Upon binding of IL-1, IL-1R1 undergoes
conformational changes and forms a heterodimer with the
accessory protein, IL-1RAcP. Then both subunits bind MyD88
proteins via their Toll/IL-1 receptor (TIR) domain. Subsequently,
MyD88 recruits the IL-1R-associated kinases, IRAK1 and IRAK4.
Reciprocal interactions and phosphorylation events lead to
dissociation of IRAK1 from the complex and its binding to TRAF6
which then activates the canonical NF-kB pathway.
IL-1R1 was shown to undergo constitutive turnover through the
endolysosomal system that is increased upon ligand binding [97].
IL-1R1 degradation requires the Tollip protein that binds ubiq-
uitylated receptor and mediates its sorting to late endosomes and
lysosomes [98]. IL-1R relocalized to lipid fractions enriched in
caveolin-1 upon binding IL-1 in primary rat astrocytes [99],
however it is not clear whether cellular entry of this receptor
requires caveolin-1 or cholesterol. In fact, the dependence of
IL-1-induced signaling on receptor internalization may be limited
to several speciﬁc signaling events. In the current model, activation
of IL-1-induced NF-kB signaling cascade proceeds from the plasma
membrane independently of receptor internalization, however
additional signaling events that required endocytosis were shown
to be necessary for full NF-kB transcriptional response [100]. In
more detail, inhibiting dynamin function did not affect p50:RelA
nuclear translocation nor its binding to DNA, but it partially
impaired IL-1-induced activation of NF-kB target genes [100]. A
follow-up study revealed that the endocytic route of IL-1R required
activation of small GTPase Rac1 [101]. These data are consistent
with the ﬁnding that overexpression of the dynamin dominant-
negative mutant or knock-down of Rac1 only partially (both by
50%) inhibited NF-kB luciferase reporter activity upon IL-1
induction [102].
Both IL-1 and IL-1R proteins contain putative nuclear localiza-
tion sequences (NLS) and were found in the cell nucleus
[97,99,103,104]. Consistently, known IL-1R adaptors, IRAK1 and
phosphoinositide 3-kinase (PI3K), were reported to translocate to
the nucleus in an IL-1-dependent manner [105,106]. Potential
nuclear translocation of IL-1R has never been excluded and could
possibly be a consequence of the above mentioned Rac1-
dependent endocytosis of this receptor [101].
Endocytic trafﬁcking was investigated for IL-36R, another
member of the IL-1 superfamily. Its signaling shares common
features with that of IL-1R. Although having a distinct ligand-
speciﬁc subunit (IL-1Rrp2, also known as IL-1R6), this receptor also
interacts with the accessory IL-1RAcp protein [107]. Upon binding
of the ligand (IL-36 a, b or g), the two proteins interact and
activate signaling cascades similar to those of IL-1. Ligand-induced
IL-36R co-localized with clathrin, an established clathrin-depen-
dent cargo transferrin and to a lesser extent with a clathrin-
independent cargo, cholera toxin [108]. This suggests that IL-36R is
internalized by several endocytic routes with preference towards
CME.
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The common gamma chain (gc, CD132) is a subunit of
heterodimeric or heterotrimeric receptors that bind interleukins
IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Among them are two receptors
IL-2R and IL-15R that consist of three different subunits with
speciﬁc functions. The gc is responsible for signal transduction, the
a chain confers ligand speciﬁcity, while b subunit (present only in
IL-2R and IL-15R) participates in both events [109]. Upon ligand
recognition, the dispersed subunits come together and the
gc recruits JAK3 tyrosine kinase which phosphorylates and
activates STAT transcription factors. Although different STAT
molecules are activated by these cytokines, IL-2, IL-7, IL-9, and
IL-15 predominantly signal through STAT5, while IL-4 acts mainly
through STAT6, and IL-21 through STAT3 and STAT1 [110,111].
The studies describing endocytosis of the gc showed that it
undergoes constitutive internalization followed by lysosomal
degradation [112]. The gc chain ectopically expressed in HeLa
cells in the absence of any ligand underwent CIE which required
dynamin, cortactin and actin polymerization [113].
Many receptors from this group undergo CIE, with IL-2R being
characterized to the highest extent. Early studies showed that IL-
2R is internalized and degraded in a constitutive manner [114], but
its decay can be accelerated by high concentrations of IL-2 [115].
The distinction between these two modes of internalization is
attributed to different regions of gc chain cytoplasmic tail, where
slow, constitutive trafﬁcking requires membrane-proximal amino
acids and the rapid, IL-2-induced internalization depends on
residues distal to the transmembrane region [116]. It is therefore
possible that gc subunit may use distinct sorting signals for its
constitutive regulation and ligand-induced endocytosis.
Despite joint internalization of all IL-2R subunits, in the later
steps the a chain was shown to be transported independently of
other chains, being directed to transferrin-positive structures,
most likely early recycling endosomes, while never reaching
lysosomes [117]. This is consistent with a relatively high stability of
the a chain. Conversely, b and g chains reached Rab7-positive
compartment and were rapidly degraded [117].
IL-2R is one of the ﬁrst signaling receptors described to undergo
CIE [118]. Its internalization occurs in detergent-resistant micro-
domains (DRMs) of the plasma membrane and requires dynamin
as well as proteins that regulate actin polymerization, namely
phosphoinositide kinase PI3K, Rho GTPase Rac1, its guanine
nucleotide exchange factor (GEF) Vav2, kinases Pak1 and Pak2,
endocytic adaptor cortactin, and Arp2/3 stimulator N-WASP
[13,119–121]. PI3K plays a central role in IL-2R internalization.
Its regulatory subunit p85 associates with IL-2-R(b) and activates
the recruitment of its catalytic p110 subunit to produce phospha-
tidylinositol (3,4,5)-trisphosphate. This induces Vav2 to activate
GTPase Rac1, which is then recruited to IL-2R-bound p85 subunit of
PI3K and stimulates Pak kinases. They promote local actin
polymerization through cortactin and N-WASP [119]. These events
likely occur at the last step of internalization, namely the vesicle
scission from the plasma membrane. A recent electron microsco-
py- and tomography-based study shed light on earlier events of
IL-2R endocytosis [122]. The authors propose a model in which
IL-2Rb internalization is initiated at the basis of membrane
protrusions, where internalization pits form and invaginate
adjacently to the base of the protrusion, thanks to the sequential
action of outward and inward forces created by actin polymerizing
machinery WAVE, N-WASP and cortactin. The scission of a newly
formed vesicle is performed by dynamin. In agreement, IL-2R was
identiﬁed among cargoes of a recently characterized clathrin-
independent endocytic route, termed fast endophilin-mediated
endocytosis (FEME), which likewise requires dynamin, Rac, PI3K,
PAK1 and actin polymerization and occurs at sites of formation ofprotrusive lamellipodia (at the leading edge of migrating cells)
[15]. Thus, the mechanisms of IL-2R endocytosis are quite well
understood, however its role in regulation of downstream
signaling is less known.
The interrelation between endocytosis and signaling was in
turn studied in the case of IL-4R. Biophysical analysis pointed out
that endogenous concentrations of IL-4Ra and common gc
subunits on the plasma membrane are too low for efﬁcient
dimerization which implies the existence of a concentration
mechanism that must occur for IL-4 signal transduction [123]. It
was proposed that newly formed endocytic structures (speciﬁcally
termed cortical endosomes, as they are close to cellular actin
cortex) allow the subunits to concentrate on their membranes,
dimerize and initiate JAK3-mediated signaling. Similarly to IL-2R
endocytosis, the formation of IL-4R-concentrating cortical endo-
somes was mediated by Rac1/Pac signaling towards actin
polymerization [124]. Another similarity in endocytosis of IL-2
and IL-4 receptors is that their subunits (speciﬁcally IL-2Rb and
IL-4Ra) contain a hydrophobic amino acid cluster that is
recognized early after ligand stimulation. It is hence possible that,
similarly to IL-4R, endocytosis of IL-2R provides membrane
environment that facilitates concentration of receptor subunits.
5. IL receptors containing the common beta chain (bc)
IL-3, IL-5 cytokines and Granulocyte-Macrophage Colony-
Stimulating Factor (GM-CSF) are important for hematopoiesis,
regulating myeloid differentiation and function, but are also
involved in inﬂammatory and allergic responses [125]. The high
afﬁnity receptors for these ligands are heterotrimers composed of a
ligand-speciﬁc a chain and a dimer of shared common chain bc.
The a chain alone has a weak ligand binding afﬁnity but it is
strongly increased upon association with the common chain [126].
In addition, bc plays a major role in transmitting ligand-activated
downstream signals, which involves JAK-STAT, Ras-MAPK, and
PI3K pathways. In human, IL-3R and the GM-CSF receptors are
expressed in multipotent as well as lineage-committed myeloid
progenitors, and IL-5R is mainly present on eosinophils and
basophils [125,127].
Endocytosis of the bc-containing IL receptors is not extensively
described, although studies that focused on IL-5R in human
eosinophils and TF-1 leukemia cells shed some light on this
subject. As shown in these models, endocytosis of IL-5R was
required for its signaling. Stimulation with IL-5 leads to the
receptor activation, ubiquitylation, internalization and lysosomal
degradation [128]. As proposed, IL-5R can be internalized via both
clathrin- and lipid raft-dependent endocytosis [128,129], however
further experiments involving depletion of speciﬁc endocytic
regulators need to be performed to verify this notion. The
phosphorylated and ubiquitylated receptor partitioned to the
detergent-soluble, non-raft membrane fractions and unspeciﬁc
inhibition of endocytosis prevented receptor association with
downstream signaling molecules [129]. Consistently, overex-
pressed ubiquitylation-deﬁcient IL-5R accumulated on the cell
surface and had impaired signaling capability [130]. Although the
function of speciﬁc endocytic routes is still not clear, it is well
documented that IL-5R requires endocytosis for its signaling.
The bc chain plays an important role both in IL-5R endocytosis
and signaling. Upon IL-5 stimulation, the cytosolic part of the bc
chain was shown to be proteasomally cleaved as a prerequisite for
endolysosomal degradation of the whole receptor complexes
[131]. This processing required tyrosine phosphorylation of the
receptor by JAK1 and JAK2 kinases and occurred after the
internalization [128]. Importantly, the inhibition of bc proteasomal
cleavage delayed lysosomal degradation of the receptor, at the
same time prolonging the JAK-STAT signaling. This leads to an
J. Cendrowski et al. / Cytokine & Growth Factor Reviews 32 (2016) 63–73 69attractive hypothesis that the timing of the bc cleavage might serve
as a way to regulate the duration of IL-5R receptor signaling from
endosomal compartments.
6. IL receptors containing the common gp130 chain
Receptors for cytokines from the IL-6 family (IL-6, IL-11, LIF,
OSM, CNTF, and CT1) share a common gp130 subunit [132]. They
form heterodimers or heterotrimers that involves one or two
gp130 molecules. Within this family, the endocytosis is best
described for IL-6R. The IL-6 cytokine is produced by and acts on
various cell types, mediating inﬂammation, cell proliferation and
differentiation [133]. The receptor for IL-6 is a heterotrimer
consisting of one ligand-speciﬁc IL-6Ra and two gp130 subunits
that oligomerize upon IL-6 binding and activate the JAK-STAT and
MAPK pathways [134,135]. Regarding STAT proteins, IL-6 predom-
inantly acts through STAT3 and to a lesser extent via STAT1 [136].
The IL-6 receptor was shown to undergo ligand-independent,
constitutive internalization which did not require activation of the
JAK-STAT pathway [137,138]. IL-6 increased the rate of receptor
internalization and lysosomal degradation [139,140] mediated by
c-CBL-driven monoubiquitylation of gp130. The monoubiquitin tag
was recognized by Hrs, which sorts activated receptors towards
lysosomal degradation [139].
The internalization route of gp130 is under debate, with
reported constitutive association with the AP-2 complex [137] or
with caveolae [141]. Further studies provided more evidence in
favor of CIE. The gp130 was found in caveolin-1-positive lipid rafts
regardless of ligand stimulation [142]. Interestingly, these rafts
also contained non-phosphorylated STAT3 molecules that under-
went phosphorylation upon IL-6 treatment. Consistently, choles-
terol-sequestering agent MbCD inhibited IL-6-induced STAT3\
DNA binding [142], while caveolin-1 depletion in human
ﬁbroblasts impaired IL-6-induced MAP kinase signaling [143].
Another study found that upon IL-6 stimulation STAT3 became
phosphorylated on early endosomes from where it subsequently
translocated to the nucleus [144]. This interaction of STAT3 withFig. 2. Cytokine receptors signal from the plasma membrane and endosomes. Ligand-act
the NF-kB or JNK signaling cascades by IL-1R and the listed TNFRSF receptors occurs at th
NF-kB or JAK-STAT pathways downstream of death receptors, LTbR or ILRs/IFNAR, 
compartment (signaling endosomes). Many ILRs, IFNAR, and possibly TNFRI and LTbR, un
recycling of cytokine receptors.endosomes was transient and once phosphorylated, STAT3
relocated to the nucleus in a manner not dependent on endocytic
trafﬁcking.
Collectively, these data suggest that STAT3 can spontaneously
bind to gp130-containing receptors both on the plasma membrane
and early endosomes but once it becomes phosphorylated it
dimerizes and translocates to the nucleus leaving the receptors
free to bind subsequent STAT3 molecules. This allows the signal
propagation as long as the JAK-bound cytoplasmic tails are
exposed, which is terminated for instance upon sequestration
into ILVs.
7. Interferon receptors
Interferons (IFNs) are key mediators of innate and acquired
antiviral response and negatively regulate proliferation of cancer
cells. IFNs of type I (a, b, k, v, t) and type II (only g) are
distinguished. Type I IFNs transmit their signals through IFNAR
heterodimeric receptor (composed of IFNAR1 and IFNAR2 sub-
units), while IFN-g binds and activates IFNGR receptor dimers
(IFNGR1 and IFNGR2). IFN-induced signaling is propagated
through the JAK-STAT pathway [145]. Activated IFNAR recruits
STAT2, which upon phosphorylation binds STAT1 and allows for its
phosphorylation [146], while IFNGR signals only through STAT1
homodimers [147]. Both IFNAR and IFNGR were initially described
to associate with caveolin-positive membrane microdomains [148]
which suggested that at least a fraction of the IFN receptors could
be internalized via lipid rafts.
Endocytosis of IFNAR and IFNGR was thoroughly investigated
by Lamaze and colleagues who showed that in HeLa cells, upon
ligand binding both receptors undergo clathrin- and dynamin-
dependent endocytosis [149]. In this study, inhibiting dynamin
function or silencing clathrin abrogated IFN-a-induced STAT
signaling as well as antiviral and antiproliferative activities of
IFN-a. In contrast, these conditions had no effect on IFNGR
signaling and function. Instead, IFN-g binding led to rapid
relocalization of a signiﬁcant fraction of its receptor to DRMsivated signaling of cytokine receptors can be regulated by endocytosis. Induction of
e plasma and is internalization-independent. Conversely, apoptotic, non-canonical
respectively, require receptor internalization and are activated from endosomal
dergo ligand-induced, lysosomal degradation while there is very little evidence for
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availability of membrane cholesterol. This is consistent with
earlier ﬁndings showing that IFNGR1 localized in caveolin-1
positive DRMs and that cholesterol sequestration inhibited IFN-
g-induced STAT1 signaling [142,150]. Collectively, these data show
that type I and II IFN receptors have distinct modes of activation.
IFNAR signaling requires clathrin- and dynamin-mediated inter-
nalization that allows for recruitment of signaling adaptors and
eventual signal termination that was conﬁrmed by subsequent
studies [151,152]. Conversely, IFNGR requires lipid rafts for its
signaling but it was not veriﬁed whether ligand-activated IFNGR
can internalize from these microdomains. Possibly, such lipid
environment could allow for selective endocytosis and the
proposed nuclear translocation of IFN-g-bound IFNGR1
[150,153], however this hypothesis is still to be addressed.
8. Perspectives
Biology of cytokine receptors is very complex as they induce
diverse signaling pathways and outputs which vary depending on
the cellular context, concentration and duration of exposure to a
ligand, as well as crosstalk with simultaneous stimuli. Under-
standing endocytic mechanisms of cytokine receptors could clarify
some of these complicated relations.
The data presented in this review underscore an important role
of endocytic internalization in biology of various cytokine
receptors. Moreover, in several cases endosomes may serve as
intracellular signaling platforms for these receptors (Fig. 2). The
NF-kB and JAK-STAT signaling pathways involve cytosolic adaptors
which are available to be recruited both at the plasma membrane
and on intracellular endosomes. Thus, the same signaling events
that take place at the plasma membrane can continue or repeat in
multiple cycles during receptor trafﬁcking until its sequestration in
the ILVs, as exempliﬁed by IL-6R-dependent activation of STAT3. In
the case for TNFR1 or LTbR, ligand-induced activation of the
canonical NF-kB pathway occurs at the plasma membrane and is
not affected by endocytosis inhibition, whereas the secondary
signaling events (apoptosis and the noncanonical NF-kB pathway,
respectively) strongly depend on internalization and signaling
from endosomes. In addition, our study showed that receptors
such as TNFR1 or LTbR may spontaneously oligomerize and
activate the NF-kB pathway from endosomes in a ligand-
independent manner upon trafﬁcking block that facilitates
accumulation of cargo on the endosomes [85]. Such mechanism
may also occur in case of unperturbed endocytosis: ligand-
stimulated IL-4R exclusively requires internalization for signal
propagation as endosomal concentration of the receptor subunits
favors their dimerization. These data underline the property of
endosomes to enable local clustering of trafﬁcked cargo thanks to
their limited size and conﬁned membrane space.
Overall, with few exceptions, interrelation between endocytosis
and signaling of cytokine receptors is poorly studied. IL-2R is very
thoroughly examined with respect to its internalization, although
is still to be discovered whether it requires endocytosis for
signaling. In contrast, such endocytic requirement for signaling has
been shown for IFNa receptor but without unraveling its
molecular mechanisms. As IFNAR differs from IL-4R in terms of
signaling adaptors and internalization route, it may use other
mechanisms of signal modulation, rather than the endosomal
concentration described above.
Collectively, two complementary approaches still need to meet
to understand the regulation of signaling initiated by cytokine
receptors. On the one hand, we require much more detailed
information about endocytic mechanisms used by cytokine
receptors. On the other hand, we should know better how
signaling complexes are formed in space and time. Despite fastprogress of knowledge about types of internalization mechanisms,
data regarding endocytosis of most cytokine receptors are still
fragmentary. Several of these receptors were only shown to use
lipid rafts for signaling, but without information if they internalize
through this portal and what the potential CIE route used would be.
Only when knowing this, one could try to determine if cytokine
receptors also use different internalization routes to activate
different signaling cascades, as exempliﬁed by EGFR. Next, data
showing how the balance between recycling and degradation is
maintained could help to locate the signaling complexes in the
subcellular compartments. This is also true for noninduced
receptors that undergo constitutive internalization such as IL-
1R, IL-2R, IL-6R, and possibly TNFRI, LTbR and gp130-containing
receptors. Internalization mechanisms can be cell type speciﬁc, for
example some CIE routes take place preferentially during cell
migration. Possibly, hematopoietic and non-hematopoietic cells
bearing cytokine receptors can be specialized towards particular
internalization and trafﬁcking routes. Verifying and understanding
these properties could greatly improve our understanding of
biology of cytokine receptors.
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